Loading…
Based on limited metadata, this FDA Warning Letter issued to Prefense LLC on April 23, 2020, concerns drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided.